Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record adds a recruitment status noting that no participants are being sought, and a new revision tag (v3.6.0) replaces the previous revision (v3.5.5) in the history.SummaryDifference0.1%

- Check20 days agoChange DetectedThe history shows that Revision: v3.5.5 was added and Revision: v3.5.4 was removed, indicating a small update to the page's version history.SummaryDifference0.0%

- Check41 days agoChange DetectedThe history now includes a new revision entry v3.5.4; the previous entry v3.5.3 was removed.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov interface/release revision (v3.5.3 instead of v3.5.2).SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.5.2 is now listed as the latest entry, and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.